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Abstract
Purpose The aim of this study was to discuss the feasibility of
laparoscopic ‘uncinate first’ pancreatoduodenectomy.
Methods The analysis included prospectively collected data
from 12 consecutive patients undergoing elective pure laparo-
scopic ‘uncinate process first’ pancreatoduodenectomy
(Group 1). They were compared with patients previously op-
erated on with a classical laparoscopic approach (Group 2).
The primary outcome was the quality of the resected specimen
(lymph node (LN) yield, R0 rate, involved resection margins).
Secondary outcomes were perioperative parameters.
Results The LN yield in Group 1 was 19.3 and in Group 2 it
was 13.9 (p = 0.03). R0 resection rates did not vary (66.7 vs.
63.2%, p = 0.84). Although the involvement of the superior
mesenteric artery margin and uncinate process margin seemed
lower in Group 1, the difference was not significant. Total
operative time (467 vs. 425 min, p = 0.13) and resection time
(221 vs. 232 min, p = 0.34) were similar in both groups. The
estimated blood loss in Group 1 was 408 ml, whereas in
Group 2 it was 392 ml (p = 0.33). Complication rates were
66.7% in Group 1 and 63.2% in Group 2 (p = 0.84). Median
length of stay was 9 days in both groups (p = 0.36).
Postoperative complication rates did not differ between
groups.
Conclusions Laparoscopic uncinate first approach is a feasi-
ble method for pancreatic head neoplasms. Achieved quality
of the specimen is comparable with the traditional laparoscop-
ic approach, whereas intra- and postoperative course is not
inferior. However, further studies on larger cohorts are re-
quired to fully establish whether the novel approach has po-
tential advantages over classical access in pancreatic head
cancer.
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Introduction
The first laparoscopic pancreatoduodenectomy (LPD) was re-
ported over 20 years ago by Gagner and Pomp. Thus far, sev-
eral comparative studies, published in recent years, have con-
firmed the feasibility of laparoscopy in cases of pancreatic head
malignancy [1, 2]. Although minimally invasive oncologic sur-
gery has become an accepted approach for many abdominal
operations, it is still used to a limited extent in pancreatic sur-
gery [3]. It is generally accepted that the laparoscopic approach
should follow the same principles as open surgery. Yet, in more
difficult cases, a concern arises about the oncologic quality of
the operation. Forced attempts to finish the procedure minimal-
ly invasively may lead to some compromises in the technique
or adjustments to difficult operative conditions and the use of
atypical surgical instruments. LPD is, without a doubt, one of
themost complex abdominal procedures, involving recognition
of difficult anatomy, meticulous vascular dissection and multi-
ple gastrointestinal tract reconstructions. For this reason, the
risk of the course of surgery not following the principles of
classical pancreatic head surgery is particularly high.
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Quite recently, some authors have suggested that the so-
called artery first approach (meaning superior mesenteric ar-
tery (SMA) dissection in the early phase of resection, before
any irreversible step is taken) has potential advantages, such
as early determination of resectability and decreased R1 re-
section rate [4–6]. So far, this approach has been described
mostly in open pancreatoduodenectomy. The data on artery
first LPD are sparse [7]. Therefore, the aim of this paper was to
discuss the feasibility of laparoscopic ‘uncinate process first’
pancreatoduodenectomy.
Methods
Setting
All procedures were performed in a university tertiary
referral unit, mostly involved in elective surgical treat-
ment of abdominal oncologic diseases. Starting from
December 2015, we have changed our approach (both in
open and laparoscopic access) to uncinate process first,
where the dissection of the SMA is performed at the very
beginning of the procedure. Any case of intraoperative
difficulties with dissection or uncertainty regarding tu-
mour infiltration is converted to open surgery. The annual
volume of our institution is 70–75 patients undergoing
pancreatoduodenectomy for various indications and 30
of them are eligible for laparoscopy. All specimens were
assessed by one of two experienced pathologists accord-
ing to the standardized protocol proposed by Verbeke
et al. [8]. R1 resection margin was defined when it was
close or <1 mm according to Esposito et al. [9].
Patients
The study included prospectively collected data from 12
consecutive patients undergoing elective laparoscopic un-
cinate process first pancreatoduodenectomy for pancreatic
ductal adenocarcinoma between December 2015 and
December 2016. All laparoscopic procedures were per-
formed by the same surgeon (AB), with extensive exper-
tise in laparoscopic hepatobiliary surgery. The uncinate
process first was compared with 19 patients with pancre-
atic ductal adenocarcinoma previously operated on with
the classical laparoscopic approach over the period of
12 months before the artery first approach was introduced.
Patients with histopathology other than pancreatic ductal
adenocarcinoma or hand-assisted/converted cases were
excluded from the final analysis. Moreover, patients with
suspected vascular infiltration or those undergoing preop-
erative chemotherapy are not submitted to laparoscopic
dissection in our institution. Figure 1 shows the patients’
flow through the study.
Measured outcomes
Our primary outcome was the quality of resected speci-
men (lymph node (LN) yield, R0 rate, involved resection
margins—posterior surface of the uncinate process, pan-
creatic neck margin, superior mesenteric artery margin,
superior mesenteric vein margin). All specimens are
assessed according to the Verbeke protocol [8]. They are
inked according to an agreed colour code to facilitate
specimen orientation. Secondary outcomes were operative
and postoperative parameters (total operative and resec-
tion time, blood loss, complication rate during hospital
stay and within 30 days postdischarge).
Operative technique
The right flexure of the colon is fully mobilized and a modi-
fied Kocher manoeuvre is performed with a wide mobilization
of the duodenum and the head of the pancreas from the retro-
peritoneal adhesions (with partial resection of the prerenal
fascia and full exposition of anterior aspect of the vena cava
and left renal vein). In the uncinate process first, the SMA is
identified at the early stage of the procedure. The dissection is
carried out along the aorta until the origin of the SMA is
identified according to the technique described by Hackert
et al. [10]. In the next step, the superior mesenteric vein
(SMV) is being exposed below the pancreas. Traction of the
duodenum and the head of the pancreas towards the anterior
abdominal wall and rotation of the small bowel mesentery
expose the infrapancreatic segment of the SMA. The dissec-
tion then follows the course of the artery towards its origin at
the aorta. Once the resectability is confirmed, common hepatic
and proper hepatic arteries and the common bile duct are iden-
tified. The gastroduodenal and right gastric arteries are clipped
and divided. The first portion of the duodenum and the first
jejunal loop are transected with Echelon® stapler. The head of
the pancreas, with the tumour, is dissected from the superior
mesenteric vessels (starting from the SMA followed by the
SMV and portal vein). The larger arterial and venous
branches, including the inferior panreaticoduodenal artery,
are clipped and cut off. The neck of the pancreas is divided
as the last step of the resection phase. Bleeding from the cut
surface of the organ is controlled with sutures. Electrocautery
is not routinely used to avoid damage of the pancreatic paren-
chyma. Additional lymphadenectomy of Group 8 (located
around the common hepatic artery), Group 9 (around the ce-
liac trunk) and Group 12 (located around the hepatic proper
artery) lymph nodes is performed. Figure 2 shows the opera-
tive field after resection.
In the ‘classical approach’, the SMA is not identified at the
beginning of the dissection phase. The neck of the pancreas is
dissected from the SMVand portal vein confluence. It is then
transected and the venous plane is followed, so that the
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uncinate process and the head of the pancreas are freed from
surrounding tissues. The SMA plane is not identified.
All anastomoses are performed laparoscopically, regardless
of the approach. Drains near pancreaticojejunostomy are left
in most patients, while drains near hepaticojejunostomy are
not placed routinely.
Statistical analysis and ethical approval
All data were analysed with Statsoft STATISTICA v.12. The
results are presented as mean ± standard deviation (SD). The
study of categorical variables used the chi-square test of inde-
pendence. The Shapiro-Wilk test was used to check for nor-
mal distribution of data and the T-student test was used for
normally distributed quantitative data. For non-normally dis-
tributed quantitative variables, the Mann-Whitney U test was
used. Results were considered statistically significant when p
value was found to be less than 0.05.
The study was approved by the local Ethics Review
Committee. All procedures were performed in accordance
with the ethical standards laid down in the 1964 Declaration
of Helsinki and its later amendments. Written informed con-
sent was obtained from all patients before surgery.
Results
Patients in Group 1 were comparable to patients in Group 2 in
regard to demographic parameters, except for ASA grade
(Table 1).
There were no significant differences in the stage of cancer
between groups. The LN yield in Group 1 was 19.3 and in
Group 2 it was 13.9 (p = 0.03). R0 resection rates did not differ
(66.7 vs. 63.2%, p = 0.84). The involved margins are present-
ed in Table 2. Although involvement of the superior mesen-
teric artery margin and uncinate process margin seemed lower
in Group 1, we did not perform the statistical analysis due to
small sample sizes.
Total operative time (467 vs. 425 min, p = 0.13) as well as
resection time (221 vs. 232 min, p = 0.34) were similar in both
groups. The estimated blood loss in Group 1 was 408 ml,
while in Group 2 it was 392 ml (p = 0.33). Complication rates
Excluded (n= 13) 
histopathology other than pancreatic ductal  
adenocarcinoma:  
 IPMN = 4 cases,  
 papilla of Vater cancer = 3 cases 
 NETs = 4 cases 
 distal common bile duct cancer = 1 case, 
 chronic pancreatitis = 1 case 
Laparoscopic resection in patients  
with pancreatic adenocarcinoma  
n=18 
Excluded (n= 6) 
 conversion = 3 cases 
 hand-assisted anastomoses 
via minilaparotomy = 3 cases 
Artery first approach (n= 12) 
Assessed for  
laparoscopic resection  
n= 31 
Assessed for  
pancreatoduodenectomy 
n= 73 
Excluded (n= 42) 
 open surgery = 42 cases 
Fig. 1 Patient flowchart
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were 66.7 and 63.2%, respectively (p = 0.84). Median length
of stay was 9 days in both groups (p = 0.36) (Tables 3 and 4).
Discussion
In this study, we have confirmed the feasibility of laparoscopic
uncinate process first approach for pancreatic head malignan-
cy. The change in the operative technique did not have any
negative influence on the operative time, blood loss and com-
plications. In addition, pathologic specimen quality was
comparable.
Currently, there is a lot of evidence that laparoscopic sur-
gery can be successfully implemented in most of gastrointes-
tinal cancer cases leading to reduced postoperative morbidity
without compromising long-term survival. It is also signifi-
cant that, nowadays, patients prefer minimally invasive access
for various reasons [11–13]. However, the surgeons’ accep-
tance for laparoscopic surgery in pancreatic head malignancy
is still low. This is due to the limited number of studies show-
ing the clinical advantages of laparoscopy over open surgery
[3]. LPD still remains an extremely difficult operation, with a
long learning curve and prolonged operative time [14].
Only recently, a modified artery first approach was de-
scribed in pancreatic head surgery, which allows early deter-
mination of SMA involvement [15]. There are several poten-
tial advantages of the artery first approach. They include the
following: better resection of mesopancreas with a more ade-
quate lymphadenectomy, reduced blood loss and an easier
identification of aberrant right hepatic artery [16]. Although
nowadays, triphasic computed tomography or endoscopic ul-
trasound allows for the delineation of resectable, borderline
resectable or non-resectable tumours, they may be insufficient
in selected cases. Therefore, the use of laparoscopy for early
assessment of SMA infiltration may have potential benefits,
one of them being a better selection of candidates for vascular
resection or patients who would benefit from neoadjuvant
chemotherapy and a second-look operation. Moreover, faster
recovery and better general status after exploratory laparosco-
py may allow introducing chemotherapy earlier.
The number of resected lymph nodes in our series is com-
parable with that of previous reports in both laparoscopic and
Fig. 2 Operative field after
resection part
Table 1 Demographic
characteristics of patient groups Parameter Group 1 (uncinate process
first approach)
Group 2 (classical approach) p value
Number of patients, n 12 19 –
Females, n (%) 6 (50%) 7 (36.8%) 0.47
Males, n (%) 6 (50%) 12 (63.2%)
Mean age, years ± SD (median) 58.0 ± 12.4 (56) 62.3 ± 8.5 (62) 0.09
BMI, kg/m2 ± SD (median) 24.5 ± 3.1 (24.5) 25.6 ± 2.8 (25.6) 0.38
ASA 2, n (%) 12 (100%) 13 (68.4%) 0.01
ASA 3, n (%) – 6 (31.6%)
Any comorbidity 8 (66.7%) 10 (52.6%) 0.44
Cardiovascular 4 (33.3%) 4 (21.1%) 0.45
Hypertension 2 (16.7%) 8 (42.1%) 0.12
Diabetes 2 (16.7%) 3 (15.8%) 0.95
Pulmonary disease 2 (16.7%) 1 (5.3%) 0.30
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open surgery [17, 18]. Although there is a difference in the
number of harvested lymph nodes between groups, we are not
certain whether this is due to the change in the operative ap-
proach. This aspect has to be confirmed in a larger trial com-
paring the classical approach with the artery first approach. In
addition, there are more accurate prognostic factors related to
lymph nodes, such as the number of positive nodes or lymph
node ratio [19]. In addition, there are no advantages of extend-
ed lymphadenectomy on survival [20]. Moreover, pancreatic
cancer spread is characterized not only by lymphatic metasta-
ses, but also by perineural invasion that may potentially lead
to lymphatic spread of cancer [21]. Therefore, a simple
lymphadenectomy, without the resection of peripancreatic soft
tissues and extrapancreatic nerve plexus, is considered
oncologically insufficient. For this reason, meticulous
skeletonization of the mesenteric vessels, with regional
lymphadenectomy and perivascular neural and soft tissue re-
moval, is highly recommended [22, 23]. According to some
Table 2 Pathologic results
Parameter Group 1 (uncinate process
first approach)
Group 2 (classical approach) p value
AJCC 0.78
AJCC II A, n (%) 7 (58.3%) 9 (47.4%)
AJCC II B, n (%) 3 (25.0%) 7 (36.8%)
AJCC III, n (%) 2 (16.7%) 3 (15.8%)
T category 0.93
pT2 3 (25.0%) 5 (26.3%)
pT3 9 (75.0%) 14 (73.7%)
N category 0.55
pN0 7 (58.3%) 9 (47.4%)
pN1 5 (41.7%) 10 (52.6%)
Lymph nodes, n (%) 19.3 ± 8.2 (16) 13.9 ± 9.4 (13) 0.03
Resection 0.84
Resection R0, n (%) 8 (66.7%) 12 (63.2%)
Resection R1, n (%) 4 (33.3%) 7 (36.8%)
Resection margin involvement
SMAM 2 4
SMVM 1 1
PUPM 2 4
PNM – –
BDM – –
R1 resection margin was defined when it was close or <1 mm according to Esposito et al.[9]
SMAM superior mesenteric artery margin, SMVM superior mesenteric veinmargin,PUPM posterior surface of the
uncinate process margin, PNM pancreatic neck margin, BDM bile duct margin
Table 3 Postoperative characteristics of patient groups
Parameter Group 1
(uncinate process first approach)
Group 2
(classical approach)
p value
Mean total operative time, min. ± SD (median) 466.7 ± 53.8 (445) 425.0 ± 85.1 (420) 0.13
Mean resection time, min. ± SD (median) 220.7 ± 47.8 (230) 232.3 ± 51.8 (245) 0.34
Mean intraoperative blood loss, ml ± SD (median) 408.3 ± 166.3 (300) 391.7 ± 180.7 (250) 0.33
Median length of hospital stay (IQR) 9 (8–12) 9 (6–12) 0.36
Patients with complications, n (%) 8 (66.7%) 12 (63.2%) 0.84
Clavien-Dindo 1, n (%) 2 (16.7%) 4 (21.1%) 0.34
Clavien-Dindo 2, n (%) 4 (33.3%) 7 (36.8%)
Clavien-Dindo 3, n (%) 2 (16.7%) –
Clavien-Dindo 5, n (%) – 1 (5.3%)
Readmission, n (%) – 1 (5.3%) -
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authors, the artery first approach is superior over the classical
in terms of better mesopancreas dissection [15]. This termwas
first used by Gockel et al. in 2007 [24]. Mesopancreas does
not contain any surrounding fascia and it is defined as an
anatomical space bounded by the pancreatic neck (anterior-
ly), pancreaticoduodenal fascia (posteriorly) and superior
mesenteric vessels (medially). It does, however, contain
lymph nodes, nerves and smaller vessels [25]. It has been
suggested that novel approach to mesenteric vessels may
facilitate mesopancreas resection, thus lowering the inci-
dence of R1 resection [21]. Although this sounds logical,
it still has to be investigated with well-designed trials to
fully answer the question whether it lowers the recurrence
rate and survival. Besides, there are no standardized proto-
cols of mesopancreas assessment as those used in rectal
cancer surgery, for instance.
According to the review by Sanjay et al., there are six
different approaches to SMA that may be considered as the
artery first approach [15]. In our series, we adapted the so-
called uncinate process first approach described in open sur-
gery by Hackert et al. [10]. In this technique, the resection is
performed in a retrograde way starting from the jejunum,
whereas the transection of the pancreas is the last step of the
resection phase. We agree with Hackert’s observations that
in this way it is possible to safely and completely dissect
the uncinate process from the retroperitoneum and the
superior mesenteric vein under visual control of the vein
and the artery.
In our material, we did not find any differences in R0/R1
rates. The R1 rate in our group is relatively high, which is due
to fact we use the classification proposed by Esposito et al.
(R1 resection margin is defined as positive margin within
<1 mm of the tumour) [9]. Lack of difference in R0 rates, on
the one hand, confirms that the artery first approach enables
comparable quality of resection. On the other hand, we must
admit that both groups were relatively small, therefore we
interpret these results cautiously.
The laparoscopic uncinate process first approach allowed
us to achieve comparable, if not better quality of the specimen.
Another important observation from our study was that it was
not associated with a worse intraoperative and perioperative
course. The resection time, intraoperative blood loss and post-
operative complications were not different between groups.
However, one of the greatest limitations of the study is that
the learning curve in the artery first approach has not been
completed yet. Although most parts of the procedure do not
differ regardless of the used approach and practically only one
particular step is different from what we have learnt, this may
still introduce bias. Besides, this single-centre analysis in-
cludes relatively small groups of patients. Nevertheless, we
clearly showed the feasibility of this technique in laparoscopic
setting.
Conclusion
In conclusion, we can confirm that the laparoscopic uncinate
first approach is feasible and all steps of the procedure can be
successfully applied to laparoscopic access. The artery first
approach helps to identify early resectability. Whether it
would increase negative margins of resection, improve
disease-free survival and increase survival are yet unknown.
More studies, including larger cohorts of patients, are required
to fully establish whether the novel approach has potential
advantages over the classical access to pancreatic head
malignancy.
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Table 4 Types of complications
according to Clavien-Dindo
classification
Group 1
(uncinate process first approach)
Group 2
(classical
approach)
I Chyle leak 1 1
Pancreatic fistula grade A 1 2
Surgical site infection – 1
II Urinary tract infection – 1
Delayed gastric emptying (requiring TPN) 3 4
Pancreatic fistula grade B 1 1
Surgical site infection (requiring antibiotics) – 1
III Biliary anastomotic leakage (reoperation) 1 –
Postoperative bleeding (reoperation) 1 –
V Death (anastomotic leakage, massive bleeding) – 1
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